Literature DB >> 28660900

Cancer immunotherapy: Macrophages steal the show.

M Teresa Villanueva.   

Abstract

Entities:  

Mesh：

Year:  2017        PMID： 28660900     DOI： 10.1038/nrd.2017.126

Source DB:  PubMed          Journal:  Nat Rev Drug Discov        ISSN： 1474-1776            Impact factor:   84.694


× No keyword cloud information.
  3 in total

1.  TCN1 is a potential prognostic biomarker and correlates with immune infiltrates in lung adenocarcinoma.

Authors:  Haining Li; Liping Guo; Zhigang Cai
Journal:  World J Surg Oncol       Date:  2022-03-14       Impact factor: 2.754

2.  Association of MSH2 Expression With Tumor Mutational Burden and the Immune Microenvironment in Lung Adenocarcinoma.

Authors:  Mingming Jia; Linli Yao; Qin Yang; Tian Chi
Journal:  Front Oncol       Date:  2020-02-21       Impact factor: 6.244

3.  Exonuclease 1 (EXO1) is a Potential Prognostic Biomarker and Correlates with Immune Infiltrates in Lung Adenocarcinoma.

Authors:  Chang-Shuai Zhou; Ming-Tao Feng; Xin Chen; Yang Gao; Lei Chen; Liang-Dong Li; De-Heng Li; Yi-Qun Cao
Journal:  Onco Targets Ther       Date:  2021-02-15       Impact factor: 4.147
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.